The yeast Tor signaling pathway is involved in G2/M transition via polo-kinase

Akio Nakashima1, Yoshiko Maruki, Yuko Imamura

  • 1Biosignal Research Center, Kobe University, Kobe, Japan.

Plos One
|May 22, 2008
PubMed

Insights

The target of rapamycin complex 1 (TORC1) regulates the G2/M transition in yeast cell division. This pathway controls the cell cycle by influencing the transport and activity of key proteins like Cdc5.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • The target of rapamycin (Tor) protein is crucial for cell growth and division.
  • Rapamycin inhibits cell growth and causes G1 cell cycle arrest.
  • The role of Tor in other cell cycle stages remains largely unknown.

Purpose of the Study:

  • To investigate the involvement of Tor in cell cycle regulation beyond G1.
  • To elucidate the specific role of the rapamycin-sensitive Tor complex 1 (TORC1) in cell division.

Main Methods:

  • Utilized temperature-sensitive yeast strains (kog1-105) affecting TORC1.
  • Administered rapamycin to yeast cells to observe cell cycle effects.
  • Analyzed the interaction between TORC1, Cdc5 (yeast polo-like kinase), and nucleocytoplasmic transport.

Main Results:

  • TORC1 is implicated in the G2/M transition, causing mitotic delay and prolonged G2 phase.
  • Overexpression of Cdc5 rescues growth defects in kog1-105 strains, indicating Cdc5 activity is affected.
  • The TORC1-Type2A phosphatase pathway regulates Cdc5's nucleocytoplasmic transport and function.

Conclusions:

  • Tor signaling, specifically TORC1, plays a novel role in regulating the G2/M cell cycle transition.
  • The TORC1 pathway influences cell proliferation by controlling the localization and activity of key cell cycle regulators like Cdc5.

Related Concept Videos

Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...